AVIENT CORP AVNT

Healthcare SIC 2821 - Plastic Materials, Synth Resins & Nonvulcan Elastomers NYSE

We are an innovator of materials solutions to help our customers succeed, while enabling a sustainable world. Our products include specialty engineered materials, performance fibers, advanced composites and color and additive solutions. We are also a highly specialized developer and manufacturer of performance enhancing additives, liquid colorants and silicone colorants. When used in this Annual Report on Form 10-K, the terms "we," "us," "our," "Avient" and the "Company" mean Avient Corporation and its consolidated subsidiaries.

Avient was formed as PolyOne Corporation on August 31, 2000, from the consolidation of The Geon Company (Geon) and M.A. Hanna Company (Hanna). Through a series of acquisitions, divestitures, operational improvements and cultural shifts, the Company has transformed to become an innovator of materials solutions. Effective June 30, 2020, the Company amended its existing Articles of Incorporation to change its name to Avient Corporation and changed its ticker symbol from "POL" to "AVNT", effective at the start of trading on July 13, 2020.

Last close 43.40 2026-09-04
Market cap $3.98B 2026-06-30 share count
52-week range 27.48 - 46.64

Valuation FY2025 figures against the last close

P/S1.2x
P/E48.8x
P/FCF20.4x
EV/EBITDA13.9x
Dividend yield2.5%
Diluted EPS0.89

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $3.26B$3.24B$3.14B$3.40B$3.32B$2.21B$2.86B$2.88B$2.59B$2.35B
Cost of revenue $2.24B$2.18B$2.25B$2.51B$2.37B$1.55B$2.21B$2.26B$1.99B$1.79B
Gross profit $1.02B$1.06B$892.5M$882.7M$943.8M$660.0M$657.2M$624.8M$596.4M$556.2M
R&D $96.7M$98.7M$90.3M$84.9M$83.2M$59.8M$50.6M$49.6M$45.3M$44.3M
SG&A $812.1M$727.4M$695.7M$639.4M$664.1M$548.4M$500.4M$446.2M$423.3M$385.8M
Operating income $203.5M$329.3M$196.8M$243.3M$279.7M$111.6M$156.8M$178.6M$173.1M$170.4M
Interest expense $115.3M$119.8M$75.2M$74.5M$59.5M$62.8M$60.8M$59.7M
Pre-tax income $111.7M$224.8M$87.3M$63.8M$203.5M$61.1M$109.4M$101.8M$111.9M$129.6M
Income tax $28.1M$54.1M$11.0M$19.3M$51.9M$11.7M$33.7M$14.4M$800.0K$28.3M
Net income $81.9M$169.5M$75.7M$703.1M$230.8M$131.6M$588.6M$159.8M-$57.7M$165.2M
EPS, basic 0.901.860.837.712.531.467.622.01-0.711.97
EPS, diluted 0.891.840.837.632.511.457.581.99-0.701.95
Shares, diluted (wtd. avg.) $91.8M$92.0M$91.8M$92.2M$92.1M$90.6M$77.7M$80.4M$82.1M$84.6M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $510.5M$544.5M$545.8M$641.1M$601.2M$649.5M$864.7M$170.9M$243.6M$226.7M
Receivables $435.0M$399.5M$399.9M$440.6M$439.9M$516.6M$330.0M$347.2M$326.2M$325.6M
Inventory $367.2M$346.8M$347.0M$372.7M$305.8M$327.5M$260.9M$284.6M$264.3M$266.4M
Total current assets $1.40B$1.42B$1.41B$1.57B$1.83B$1.60B$1.51B$998.8M$1.07B$949.5M
Property, plant and equipment $988.8M$955.3M$1.03B$1.05B$672.3M$694.9M$407.4M$384.5M$354.2M$321.4M
Goodwill $1.76B$1.66B$1.72B$1.67B$1.28B$1.31B$685.7M$639.1M$599.3M$521.5M
Other intangibles $1.49B$1.45B$1.59B$1.60B$925.2M$1.01B$469.3M$422.4M$398.6M$342.7M
Total assets $6.03B$5.81B$5.97B$6.08B$5.00B$4.87B$3.27B$2.72B$2.71B$2.74B
Accounts payable $410.0M$417.4M$432.3M$454.4M$429.5M$471.7M$287.7M$305.0M$296.3M$320.9M
Short-term debt $500.0K$7.7M$9.5M$2.2M$8.6M$18.6M$18.4M$19.4M$32.6M$18.5M
Total current liabilities $846.3M$756.1M$773.6M$869.4M$940.6M$801.0M$702.5M$557.6M$570.6M$509.9M
Long-term debt $1.92B$2.06B$2.07B$2.18B$1.85B$1.85B$1.21B$1.34B$1.28B$1.24B
Retained earnings $1.87B$1.88B$1.81B$1.82B$1.21B$1.06B$1.00B$472.9M$387.1M$491.2M
Total equity $2.37B$2.31B$2.34B$2.35B$1.79B$1.71B$1.05B$540.6M$599.4M$725.5M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $301.6M$256.8M$201.6M$398.4M$233.8M$221.6M$300.8M$253.7M$202.4M$227.6M
Depreciation and amortisation $185.9M$179.7M$188.8M$163.1M$144.2M$111.8M$87.5M$88.5M$97.4M$100.5M
Stock-based compensation $9.1M$15.4M$13.2M$13.2M$11.2M$11.3M$11.6M$10.9M$10.2M$8.4M
Capital expenditure $106.6M$121.9M$119.4M$105.5M$100.6M$63.7M$81.7M$76.0M$79.6M$84.2M
Investing cash flow -$97.0M-$120.6M-$94.2M-$504.0M-$150.2M-$1.43B$611.9M-$170.3M-$119.4M-$235.4M
Financing cash flow -$257.1M-$120.9M-$201.7M$166.4M-$114.6M$982.0M-$218.3M-$148.1M-$72.7M-$40.3M
Dividends paid $98.8M$94.0M$90.2M$86.8M$77.7M$71.3M$60.3M$56.1M$44.1M$40.2M
Buybacks $0$0$36.4M$4.2M$22.4M$26.9M$123.0M$70.7M$86.2M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001122976-26-000039.

Others in SIC 2821

TickerCompanyMarket capP/ERevenue growth
DOW DOW INC. $21.22B -7.0%
DD DuPont de Nemours, Inc. $17.77B 1.9%
ALB ALBEMARLE CORP $14.90B -4.4%
EMN EASTMAN CHEMICAL CO $8.14B 17.4x -6.7%
HXL HEXCEL CORP /DE/ $6.96B -0.5%
ROG ROGERS CORP $2.28B -2.3%
PCT PureCycle Technologies, Inc. $1.28B
ASIX AdvanSix Inc. $471.2M 9.7x 0.3%